[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status and Outlook 2018-2025

August 2018 | 122 pages | ID: G02357F6447EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Biocon Ltd
  • Coherus BioSciences Inc
  • Livzon Pharmaceutical Group Inc
  • Momenta Pharmaceuticals Inc
  • Mycenax Biotech Inc
  • Oncobiologics Inc
  • Oncodesign SA
  • Panacea Biotec Ltd
  • Regeneron Pharmaceuticals Inc
  • Sandoz International GmbH
  • UCB SA
Market by Type
  • Etanercept Biosimilar
  • Tocilizumab Biosimilar
  • Sarilumab
  • Adalimumab Biosimilar
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Polyarticular Juvenile Idiopathic Arthritis Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Etanercept Biosimilar
  3.1.2 Tocilizumab Biosimilar
  3.1.3 Sarilumab
  3.1.4 Adalimumab Biosimilar
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Etanercept Biosimilar Production by Region
    6.1.1.2 Tocilizumab Biosimilar Production by Region
    6.1.1.3 Sarilumab Production by Region
    6.1.1.4 Adalimumab Biosimilar Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Etanercept Biosimilar Demand by Region
    6.2.1.2 Tocilizumab Biosimilar Demand by Region
    6.2.1.3 Sarilumab Demand by Region
    6.2.1.4 Adalimumab Biosimilar Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Biocon Ltd
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Coherus BioSciences Inc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Livzon Pharmaceutical Group Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Momenta Pharmaceuticals Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Mycenax Biotech Inc
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Oncobiologics Inc
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Oncodesign SA
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Panacea Biotec Ltd
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Regeneron Pharmaceuticals Inc
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Sandoz International GmbH
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 UCB SA

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Polyarticular Juvenile Idiopathic Arthritis Drug Industry Dynamics & Regulations List
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status by Type 2015-2018E, in USD Million
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status by Application 2015-2018E, in USD Million
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status by Application 2015-2018E, in Volume
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market by Region 2015-2018E, in USD Million
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Region in 2018, in USD Million
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market by Region 2015-2018E, in Volume
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Region in 2018, in Volume
Table Etanercept Biosimilar Production Value by Region 2015-2018E, in USD Million
Table Etanercept Biosimilar Production Volume by Region 2015-2018E, in Volume
Table Tocilizumab Biosimilar Production Value by Region 2015-2018E, in USD Million
Table Tocilizumab Biosimilar Production Volume by Region 2015-2018E, in Volume
Table Sarilumab Production Value by Region 2015-2018E, in USD Million
Table Sarilumab Production Volume by Region 2015-2018E, in Volume
Table Adalimumab Biosimilar Production Value by Region 2015-2018E, in USD Million
Table Adalimumab Biosimilar Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Etanercept Biosimilar Market Size by Region 2015-2018E, in USD Million
Table Etanercept Biosimilar Market Size by Region 2015-2018E, in Volume
Table Tocilizumab Biosimilar Market Size by Region 2015-2018E, in USD Million
Table Tocilizumab Biosimilar Market Size by Region 2015-2018E, in Volume
Table Sarilumab Market Size by Region 2015-2018E, in USD Million
Table Sarilumab Market Size by Region 2015-2018E, in Volume
Table Adalimumab Biosimilar Market Size by Region 2015-2018E, in USD Million
Table Adalimumab Biosimilar Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalPolyarticular Juvenile Idiopathic Arthritis Drug Forecast by Type 2019F-2025F, in USD Million
Table Polyarticular Juvenile Idiopathic Arthritis Drug Forecast by Type 2019F-2025F, in Volume
Table Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Region 2019F-2025F, in Volume
Table Biocon Ltd Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Biocon Ltd
Table Coherus BioSciences Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Coherus BioSciences Inc
Table Livzon Pharmaceutical Group Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Livzon Pharmaceutical Group Inc
Table Momenta Pharmaceuticals Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Momenta Pharmaceuticals Inc
Table Mycenax Biotech Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Mycenax Biotech Inc
Table Oncobiologics Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Oncobiologics Inc
Table Oncodesign SA Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Oncodesign SA
Table Panacea Biotec Ltd Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Panacea Biotec Ltd
Table Regeneron Pharmaceuticals Inc Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Regeneron Pharmaceuticals Inc
Table Sandoz International GmbH Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of Sandoz International GmbH
Table UCB SA Information
Table Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Cost, Margin of UCB SA
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Volume by Company 2015-2017, in Volume
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Polyarticular Juvenile Idiopathic Arthritis Drug Picture
Figure Polyarticular Juvenile Idiopathic Arthritis Drug Industry Chain Diagram
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Volume 2015-2018E, in Volume
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status by Type 2015-2018E, in Volume
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Polyarticular Juvenile Idiopathic Arthritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Price Forecast 2019F-2025F
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Gross Margin Forecast 2019F-2025F
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Company in 2018
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories